Roughly 300 million people are visually impaired—38 million of whom are blind and most of whom live in so-called developing countries. However, there are many institutions with specific campaigns aimed at eliminating preventable blindness.
Every ophthalmologist requires precise surgical tools with which he or she can perform surgery safely and accurately in order to ensure optimal outcomes. The availability of high-quality microsurgical instruments has increased over the past decade with manufacturers continually modifying and optimising existing instruments.
The European Commission has granted marketing authorisation for cenegermin eye drops (Oxervate, Dompé) for the treatment of moderate to severe neurotrophic keratitis.
A three-day exhibition that shows how people with visual impairments can appreciate a wide range of art forms was unveiled at the Science Museum on 8th August 2017.
Adding objective point-of-care dry eye diagnostics to your practice has deep, measurable effects, including more accurate and consistent IOL power calculations.
It will soon be time for the FIL – Feira Internacional de Lisboa in Lisbon, Portugal to open its doors to the ophthalmic community for the 35th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), taking place between the 7th and 11th October 2017.
Today, a visit to the commercial exhibitions of major meetings is a real show, with companies’ booths offering amazing high-tech devices that promise to address the specific needs we have in our practices. Although such technology impresses us, we seldom receive information on the evidence-based data surrounding its effectiveness, its cost-benefit analysis and the potential for obsolescence.
High-intensity focused ultrasound cyclocoagulation is safe and effective in most refractory glaucomatous eyes. Complete success was achieved in 80% (24/30) of treated eyes that had undergone the maximum of three procedures.
Two questionnaires used to measure quality of life in people with strabismus overlap but differ in important areas, according to researchers.
This case study presents the results and advantages of phacoemulsification, which Dr Dieter W Klass and his team applied after previous implantation of an iris-fixated phakic IOL (pIOL) (Artisan, Ophtec) for the correction of high myopia without explantation of the pIOL.